Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phas...

por Mori, Ryusaburo, Honda, Shigeru, Gomi, Fumi, Tsujikawa, Akitaka, Koizumi, Hideki, Ochi, Haruka, Ohsawa, Shino, Okada, Annabelle Ayame
Publicado 2023